Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Ariano

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|September 29, 2005
Evaluating ciprofloxacin dosing for Pseudomonas aeruginosa infection by using clinical outcome-based Monte Carlo simulationsSheryl Zelenitsky, Robert Ariano, Godfrey Harding, et al.
International Journal of Antimicrobial Agents|October 30, 2016
Multifaceted antibiotic treatment analysis of methicillin-sensitive Staphylococcus aureus bloodstream infectionsZhanni Weber, Robert Ariano, Philippe Lagacé-Wiens, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2002
Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluidsSheryl Zelenitsky, Christine Franczuk, Adrian Fine, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
Preferential emergence of reduced vancomycin susceptibility in health care-associated methicillin-resistant Staphylococcus aureus isolates during continuous-infusion vancomycin therapy in an in vitro dynamic modelSheryl Zelenitsky, Noha Alkurdi, Zhanni Weber, et al.
Jac-Antimicrobial Resistance|April 30, 2026
Unlocking antimicrobial stewardship optimization potential in Canadian hospitals: a mixed-methods needs assessmentMonica Augustyniak, Robert Ariano, Paul Bonnar, et al.
International Journal of Antimicrobial Agents|January 15, 2013
Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shockSheryl Zelenitsky, Ethan Rubinstein, Robert Ariano, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 15, 2016
Microbiological Trends and Antimicrobial Resistance in Peritoneal Dialysis-Related Peritonitis, 2005 to 2014Sheryl A Zelenitsky, Jacy Howarth, Philippe Lagacé-Wiens, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 7, 2005
Are most patients on the labour floor in active labour? A descriptive study of a Canadian obstetrical unitChristiane Raby, Michael Helewa, Gail Hazlitt, et al.
The Canadian Journal of Hospital Pharmacy|October 26, 2020
Clinical Blood Isolates from Hemodialysis Patients: Distribution of Organisms and Antimicrobial Resistance, 2007-2014Courtney K Lawrence, Chris Sathianathan, Mauro Verrelli, et al.
Expert Review of Anti-Infective Therapy|September 26, 2024
Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registryGeorge G Zhanel, Rita Dhami, Melanie Baxter, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|September 29, 2005
Evaluating ciprofloxacin dosing for Pseudomonas aeruginosa infection by using clinical outcome-based Monte Carlo simulationsSheryl Zelenitsky, Robert Ariano, Godfrey Harding, et al.
International Journal of Antimicrobial Agents|October 30, 2016
Multifaceted antibiotic treatment analysis of methicillin-sensitive Staphylococcus aureus bloodstream infectionsZhanni Weber, Robert Ariano, Philippe Lagacé-Wiens, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2002
Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluidsSheryl Zelenitsky, Christine Franczuk, Adrian Fine, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
Preferential emergence of reduced vancomycin susceptibility in health care-associated methicillin-resistant Staphylococcus aureus isolates during continuous-infusion vancomycin therapy in an in vitro dynamic modelSheryl Zelenitsky, Noha Alkurdi, Zhanni Weber, et al.
Jac-Antimicrobial Resistance|April 30, 2026
Unlocking antimicrobial stewardship optimization potential in Canadian hospitals: a mixed-methods needs assessmentMonica Augustyniak, Robert Ariano, Paul Bonnar, et al.
International Journal of Antimicrobial Agents|January 15, 2013
Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shockSheryl Zelenitsky, Ethan Rubinstein, Robert Ariano, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 15, 2016
Microbiological Trends and Antimicrobial Resistance in Peritoneal Dialysis-Related Peritonitis, 2005 to 2014Sheryl A Zelenitsky, Jacy Howarth, Philippe Lagacé-Wiens, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 7, 2005
Are most patients on the labour floor in active labour? A descriptive study of a Canadian obstetrical unitChristiane Raby, Michael Helewa, Gail Hazlitt, et al.
The Canadian Journal of Hospital Pharmacy|October 26, 2020
Clinical Blood Isolates from Hemodialysis Patients: Distribution of Organisms and Antimicrobial Resistance, 2007-2014Courtney K Lawrence, Chris Sathianathan, Mauro Verrelli, et al.
Expert Review of Anti-Infective Therapy|September 26, 2024
Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registryGeorge G Zhanel, Rita Dhami, Melanie Baxter, et al.
Pageof 2